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Abstract
Protandim, a well defined dietary combination of 5 well-established medicinal plants, is known to induce endogenous
antioxidant enzymes, such as manganese superoxide dismutase (MnSOD). Our previous studies have shown through the
induction of various antioxidant enzymes, products of oxidative damage can be decreased. In addition, we have shown that
tumor multiplicity and incidence can be decreased through the dietary administration of Protandim in the two-stage skin
carcinogenesis mouse model. It has been demonstrated that cell proliferation is accommodated by cell death during DMBA/
TPA treatment in the two-stage skin carcinogenesis model. Therefore, we investigated the effects of the Protandim diet on
apoptosis; and proposed a novel mechanism of chemoprevention utilized by the Protandim dietary combination.
Interestingly, Protandim suppressed DMBA/TPA induced cutaneous apoptosis. Recently, more attention has been focused
on transcription-independent mechanisms of the tumor suppressor, p53, that mediate apoptosis. It is known that
cytoplasmic p53 rapidly translocates to the mitochondria in response to pro-apoptotic stress. Our results showed that
Protandim suppressed the mitochondrial translocation of p53 and mitochondrial outer membrane proteins such as Bax. We
examined the levels of p53 and MnSOD expression/activity in murine skin JB6 promotion sensitive (P+) and promotion-
resistant (P-) epidermal cells. Interestingly, p53 was induced only in P+ cells, not P- cells; whereas MnSOD is highly expressed
in P- cells when compared to P+ cells. In addition, wild-type p53 was transfected into JB6 P- cells. We found that the
introduction of wild-type p53 promoted transformation in JB6 P- cells. Our results suggest that suppression of p53 and
induction of MnSOD may play an important role in the tumor suppressive activity of Protandim.
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Introduction
Apoptosis is an intricate pathway triggered by various sources,
such as genotoxic stress, DNA damage, cytotoxicity and
irradiation. It involves both transcription-dependent, as well as,
post translational processes. Apoptosis is deeply involved in the
early stage of skin carcinogenesis [1]. With carcinogenesis being a
multifactorial disease that involves cell proliferation, inflammation
and oxidative stress-mediated signal transduction, the two-stage
skin carcinogenesis model uses a chemical-induced carcinogenesis
approach to study the biochemical and histological changes that
occur in various stages of tumorigenesis. Initially, a subcarcino-
genic dose of 12-dimethylbenz[a]anthracene [DMBA] is applied
to initiate DNA damage resulting in the formation of Ras-mutated
skin cells. During the initial stages of skin carcinogenesis, a tumor
promoting agent, such as the phorbol ester, 12-O-tetradecanoyl-
phorbol-13-acetate, [TPA] is repeatedly applied to the skin to
promote the clonal expansion of Ras- mutated cells. During
DMBA/TPA treatment, both tumor suppressor gene and
oncogene activation occur simultaneously leading to downstream
oxidative stress propagation. Consistent with that, TPA is known
to induce oxidant formation and subsequent damage to macro-
molecules [2]. Consequently, the cellular response has been shown
to increase skin epidermal hyperplasia and inflammation. The
tumor suppressor p53 is also activated during this process.
Interestingly, there’s also an increase in p53 mitochondrial
translocation. Other than a well-known skin tumor promoter,
low concentrations of TPA have been shown to induce apoptotic
cell death either alone or in combination with anti-cancer drugs in
human pancreas cancer cells [3], and human prostate cancer cells
[4,5]. In addition, it has been further demonstrated that apoptosis
precedes cell proliferation [1] which clearly supports the notion
that cell death is another key contributing event during cancer
development. Oxidative stress has been recognized to play a
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shown that oxidative stress is a mediator of apoptosis. Cellular
homeostasis relies on the balance between pro-oxidants and
antioxidants. However, processes such as oxidative stress shift this
homeostatic balance towards increased pro-oxidant formation. As
result, various morphological and biochemical modifications occur
that initiate both transcription dependent and post-translational
processes of apoptosis. Apoptosis can be characterized by various
morphological changes such as DNA fragmentation, cell shrinkage
and chromatin condensation. Nevertheless, the activation of the
tumor suppressor p53 remains an extensively studied pathway in
the field of programmed cell death. p53 is activated early during
carcinogenesis and contributes to the propagation of oxidative
stress. It has been demonstrated that p53-mediated apoptosis is
preceded by activation of various oxidoreductases and reactive
oxygen species [ROS] generation prior to mitochondrial pertur-
bation [6]. A fraction of p53 is localized in mitochondria at the
onset of p53-dependent apoptosis preceding changes in mitochon-
drial membrane potential, cytochrome c release and caspase
activation [7]. Consistent with that, previous studies suggest that
mitochondrial p53 physically interacts with manganese superoxide
dismutase [MnSOD], leading to inactivation of its enzymatic
activity [1]. Interestingly, the reduction of antioxidant activity
contributes to oxidative stress propagation which leads to
downstream cancer development. Similar results have been
observed in UV-induced skin carcinogenesis mouse models [8].
As aforementioned, DMBA/TPA treatment also leads to onco-
gene activation. It has been demonstrated that the Ras/Rac/
NADPH oxidase/p53/apoptosis circuitry may potentially exist in
Ras-mutated skin cells. Nevertheless, considerable attention is
being focused on the link between p53-induced apoptosis,
oxidative stress propagation and mitochondria. Thus, p53 may
mediate apoptosis by mechanisms that are both transcriptionally
dependent and independent; and the generation of oxidative stress
may serve as an important mechanism during carcinogenesis. This
poses the question: Can apoptosis be modulated by regulators of
oxidative stress? MnSOD is a nuclear encoded primary antioxidant
that resides in the mitochondria. Previous studies have demonstrat-
edthat overexpressionofMnSODcanreducebothtumorincidence
and multiplicity in both in vitro and in vivo. It is known that various
dietary components can induce endogenous antioxidant enzymes.
We have demonstrated this same paradigm with the use of
Protandim, a dietary combination of five extensively studied
medicinal plants, given via dietary administration [9]. One capsule
of Protandim consists of the following ingredients: B. monnieri (45%
bacosides), 150 mg, S. marianum (70–80% silymarin), 225 mg; W.
somnifera (1.5% withanolides), 150 mg; C. sinensis (98% polyphenols
and 45% (-)-epigallocatechin-3-gallate), 75 mg; and C. longa (95%
curcumin), 75 mg [10]. All of the ingredients of Protandim have
individually shown cytoprotective activity in mitigating oxidative
stress in both in vivo and in vitro studies [11–16]. Within three-
weeks, the Protandim diet was able to significantly induce
endogenous antioxidant enzymes such as catalase, MnSOD and
copper/zinc superoxide dismutase [Cu/ZnSOD] in vivo without
signs of overt toxicity. As a result, the Protandim diet exhibited its
anti-carcinogenic activity by reducing tumor incidence and
multiplicity via modulating oxidative stress through the induction
of endogenous antioxidant enzymes [9]. Therefore, further
mechanistic insight is needed to determine how modulation of
antioxidant expression/activity via Protandim affects p53-mediated
mitochondrial functions. In this study, we investigated the effects of
Protandimoncutaneousapoptosis,p53mitochondrialtranslocation
and compared the p53 and MnSOD status between promotable
and non-promotable skin epidermal cells.
Materials and Methods
2.1 Cell line, reagents and treatment
Murine skin epidermal JB6 response variants: stably responsive
JB6 (P+, CL41) and nonresponsive JB6 (P-, CL30-7b) to tumor
promoter-induced transformation were purchased from American
Type Culture Collection (ATCC, Rockville, MD). These cells
were cultured and maintained as previously described [17]. The
cells were grown in EMEM medium supplemented with 4% fetal
bovine serum, 2 mM of L-glutamine, 50 mg/ml penicillin and
50 mg/ml streptomycin. TPA (Sigma) was prepared as a 1 mM
stock solution in dimethylsulfoxide (DMSO). The TPA stock
solution was diluted directly in the cell culture medium, with the
resulting concentration being 100 nM.
2.2 Anchorage-independent growth assay in soft agar
Soft agar transformation assays were carried out in six-well
plates for the experiment. The bottom of each well was coated
with 3.5 ml of 0.5% agar in EMEM (10% FBS). A total of 100,000
JB6 cells were suspended in 0.75 ml of 0.33% agar in EMEM
(10% FBS), layered on top and incubated for 7 days. To detect the
tumor suppressive effect of Protandim in JB6 P+ cells, both layers
of agar were supplemented with TPA (5 nM), Protandim extract +
TPA, Protandim extract (final dilution: 1 ml/ml) alone, or ethanol
(EtOH; vehicle control). The colonies formed were counted via
Neutral Red staining. The transformation response was expressed
as the number of colonies formed per 100,000 cells per well (the
results were shown in Table S1). To detect how p53 affects cell
transformation in non-promotable JB6 (P-) cells, cells were seeded
in 6-well plates and incubated for 24 h. FuGENE HD reagent
(Roche Applied Science) was used to transfect 5 mg HA tagged
p53- (wild-type) or GFP-pcDNA3 vectors into JB6 P- cells during a
48 h incubation period. The GFP-conjugated-pcDNA3.1 vector
was used to monitor the transfection efficiency and served as a
control. Cells were then detached and subjected to the soft agar
assay. The transformation response was expressed as the number
of colonies formed per 100,000 cells per well.
2.3 Detection of cutaneous apoptosis during early stage
skin carcinogenesis
Skin tissues were fixed in 4% formaldehyde and processed for
histopathology. Apoptotic cells were counted using light micros-
copy. Ultrastructural features were used to identify apoptosis, such
as cell shrinkage, chromatin condensation, formation of cytoplas-
mic blebs and apoptotic bodies. Conventional electron microscopy
of mouse skin tissues was used to examine and photograph
apoptotic and mitotic cells using a Hitachi H-600 electron
microscope. Dr. Xin Gu, a certified pathologist performed the
pathological examination to confirm the morphological charac-
teristics of the cutaneous apoptotic cells.
2.4 Dietary prevention of mouse skin carcinogenesis
The two-stage skin carcinogenesis study and dietary adminis-
tration of Protandim were performed as previously described [9].
Non-tumor tissues were carefully collected for biochemical and
histological studies.
2.5 Isolation of mitochondrial fraction from skin cells
Skin epidermal cells were stripped and collected as previously
described [18]. Cells were then suspended in 2 ml of mitochondria
isolation buffer [0.225 M mannitol, 0.075 M sucrose, 1 mM
EGTA (pH adjusted to 7.4 with 0.5 M Tris)] in a 10-ml Wheaton
homogenizer tube and carefully homogenized three times with
Protandim on Apoptosis
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by centrifugation at 2,500 rpm (,600 g) twice for 5 min. The
supernatant was filtered through a nylon screen cloth (Small Parts,
Inc., Miami Lakes, FL) and then centrifuged at 10,000 rpm
(,9,000 g) for 10 min. Supernatant was kept and designated as
supernatant fraction. The pellet was washed by adding 0.5 ml of
mitochondria isolation buffer and centrifuging at 10,000 rpm for
5 min. This washing was repeated twice. The mitochondrial pellet
was resuspended in 50–100 ml of mitochondria isolation buffer
containing the protease inhibitor cocktail (Research Products
International Corp.; Mount Prospect, IL). This fraction was
labeled as the mitochondria fraction and kept at 280uC. The
purity of the mitochondrial fractions has been confirmed by trace
contamination of a nuclear marker, proliferating cell nuclear
antigen, [PCNA].
2.6 Preparation of total cell lysate of JB6 cells
JB6 cells were collected by centrifugation and resuspended in
RIPA Buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% Na.
Deoxycholate, and 1% Triton 6100) supplemented with the
protease inhibitor cocktail (5 mg/ml each of pepstatin, leupeptin,
and aprotinin) for 10 s (Sonic Dismembrator Model 100, scale 2,
Fisher Scientific), sonicated, incubated on ice, and centrifuged.
2.7 Western blot analysis
Mitochondrial fractions prepared from the mouse skin tissues
were used to detect mitochondrial p53 and Bax expression. The
whole cell lysate prepared from JB6 cells was used to detect the
induction of p53 and Bax expression by TPA. Thirty micrograms
of the protein samples were separated on a 10% SDS-PAGE gel
and transferred to nitrocellulose membrane. Ponceau staining was
used to monitor the uniformity of the transfer. The membrane was
blocked in Blotto [5% milk, 10 mm Tris-HCL (pH 8.0), 150 mM
NaCl and 0.05% Tween-20] for 1 h at room temperature. Anti-
p53 antibody (FL-393, Santa Cruz Biotechnology, Santa Cruz,
CA) and anti-Bax antibody (P-19, Santa Cruz Biotechnology,
Santa Cruz, CA) were added in 1:1000 dilutions and the
membrane was incubated for 2 h at room temperature. After
washing, the membrane was incubated with horseradish peroxi-
dase conjugated secondary antibodies (Santa Cruz) at a 1:1000
dilution. For loading controls, succinate dehydrogenase subunit B,
anti-SDHB (FL280, Santa Cruz) was used as a mitochondrial
marker; and glyceraldehyde-3-phosphate dehydrogenase, anti-
GAPDH (Santa Cruz) for total cell lysate. The antibody bands
were visualized by the enhanced chemiluminescent detection
system (ECL, Amersham). Image J 1.386 Software was used for
densitometric analysis for protein bands obtained by Western blot
analysis, and the ratio of the density of the target protein to the
density of the loading control was plotted and analyzed using
GraphPad Prism 3 software.
2.8 MnSOD activity assay
The nitroblue tetrazolium- bathocuproine sulfonate (NBT-BCS)
assay was used to measure the MnSOD activity. Total cell lysate
was prepared in 50 mM phosphate buffer. The assay buffer
contained xanthine-xanthine oxidase which was responsible for
superoxide generation. As a result, NBT was reduced by
superoxide to form the blue product formazan. The presence of
MnSOD inhibited the NBT reduction. The data was plotted as
units per milligram of protein. One unit of activity was defined as
the amount of protein needed to inhibit 50% of the NBT
reduction rate. NaCN (5 mM) was used to measure MnSOD
activity.
2.9 Detection of the levels of the reactive oxygen species
(ROS) in JB6 cells
JB6 (both P- and P+) cells were seeded into 96 well plates (1610
5
cells per well) and incubated overnight. The next day, growth
medium was replaced with fresh medium containing the vehicle
(0.1% DMSO) or TPA (100 nmol), and cells were incubated for
1 h. Medium was removed and replaced with fresh medium
containing 10 mMH 2DCF-DA (Molecular Probes, Eugene, OR),
and cells were incubated for 15 min. DCF fluorescence was
detected using a fluorescence plate reader (Synergy HT, BioTek,
Winooski, VT; excitation: 485 nm; emission: 528 nm).
2.10 Statistical analysis
Student’s t-test was used for two-group comparison, and one-
way ANOVA followed by Newman-Keuls post-test was used for
multi-group comparisons. Data were reported as means 6
standard error (S.E.M.). p,0.05 was considered significant. For
experiments including both TPA and Protandim treatments, two-
way ANOVA was used followed by the Tukey-Kramer method for
multiple comparisons. Two-way analysis of variance (ANOVA)
was used to assess the effects of TPA and Protandim on the
number of apoptotic cells present per 100 cells. Since there was an
interaction effect of Protandim and TPA on number of apoptotic
cells and the sample size are unequal among the factors, the least
square means were estimated and compared among the
combinations of these two factors. Tukey-Kramer method was
used in the adjustment for multiple comparisons. Statistical
software SAS system 9.3 (SAS Inc. Gary, NC) was used for two-
way ANOVA data analysis.
Results
Protandim suppressed DMBA/TPA induced apoptosis
Apoptosis is a prominent biological outcome following carcino-
gen treatment [1,19]. Histological examination of mouse skin tissues
treated with DMBA/TPA also showed frequent apoptosis, in
addition to adjacent single cell mitosis. Previous studies have
demonstrated that Protandim suppresses cutaneous proliferation
and inflammation. Since DMBA/TPA also causes cell death, we
investigated the effects of Protandim on cutaneous apoptosis. We
found that skin tissues from mice treated with DMBA/TPA
exhibited characteristic hyperplasia within the epidermal layer.
Within this treatment group, the apoptotic cells were typically close
to mitotic cells (an EM picture of an apoptotic cell and a
neighboring mitotic cell was shown in Figure S1). The apoptotic
keratinocytes resembled shrunken cells with dense staining with an
eosinophillic cytoplasm. As summarized in Figure 1, there were
approximately 6 apoptotic cells per 100 cells in the DMBA/TPA
treatment group. Interestingly, there were less than 1 apoptotic cell
per 100 cells in the vehicle control (DMSO) and 1 apoptotic cell per
100cellsinthe Protandimdiet fedDMBA/TPA group.Overall, the
Protandim diet reduced DMBA/TPA-mediated apoptosis.
Protandim suppressed DMBA/TPA induced p53/Bax
mitochondrial translocation
Previous studies have found that p53 is activated upon TPA
treatment; interestingly, p53 also translocates into mitochondria
[1]. Since it is known that p53 mitochondrial translocation can
mediate apoptosis, we studied the effects of Protandim on p53
mitochondrial translocation. As shown in Figure 2, TPA induced
p53 mitochondrial translocation in mice fed the basal diet.
However, when given Protandim, via dietary administration, we
observed a significant decrease in p53 mitochondrial translocation,
Protandim on Apoptosis
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p53-mitochondrial translocation. Bax, as a p53 transcriptional
target, is an important player in cellular apoptosis. It has been
suggested that p53 interacts with Bax to facilitate mitochondrial
translocation [20]. Therefore, we investigated the effects of the
Protandim diet on Bax mitochondrial expression. Similarly, we
found that TPA induced Bax mitochondrial expression. However,
when fed the Protandim diet, we also observed a significant
decrease in TPA-mediated Bax mitochondrial expression. This
suggests that Protandim, when given via dietary administration,
modulates p53 mitochondrial translocation and decreases Bax
expression levels in mitochondria.
TPA induced p53 activation and apoptosis only in
promotable, not non-promotable skin epidermal cells
Cell death accompanies cell proliferation during skin carcino-
genesis. Can early-stage p53 signaling benefit cell growth? We
performed our initial studies using clonal variants of the skin
epidermal JB6 cell line: tumor promotion sensitive (P+)a n d
-resistant (P-) cells. Herein, JB6 P+ and P- cells were treated with
TPA (100 nM) for 1 h and 24 h and compared to vehicle control
(DMSO) treated cells to understand the possible involvement of p53
in tumor promotion. As shown in Figure 3, our results indicate that
as early as 1 h after TPA treatment, p53 expression was induced in
thetotal cell lysate ofJB6P+ cells.However,thiswas notseen inJB6
P-cells.Thissuggeststhat p53expressionpotentiallyplaysa keyrole
in the early induction of tumor promotion. In addition, this global
expression of p53 is sustained for 24 h after TPA treatment.
Nevertheless, Bax, a pro-apoptotic protein of the Bcl-2 family, was
also induced with TPA treatment. Bax, a transcriptional target of
p53, is often associated with an increase inapoptosis intargeted cells
[21]. To further characterize the role of wild-type p53 in tumor-
promotion, promotion-resistant JB6 (P-) cells were transfected with
wild-type p53, treated with TPA [5 nM] and analyzed for
tumorigenicity using the soft agar assay. Interestingly, wild-type
p53 transfected cells formed colonies at a significantly higher level
compared to control cells treated in a similar manner (Table 1).
Therefore, these results suggest the involvement of p53 signaling in
the early stages of tumor promotion.
Non-promotable JB6 cells showed higher MnSOD
expression and activity and lower levels of oxidative
stress than promotable cells
MnSOD is a nuclear-encoded primary antioxidant enzyme
known to protect the mitochondria from oxidative damage [22].
Previous studies have shown that MnSOD is the only antioxidant
enzyme that when overexpressed can suppress tumor incidence and
Figure 1. Protandim suppressed DMBA/TPA induced apopto-
sis. Skin tissues from each treatment group were collected at the end
of the skin carcinogenesis study. Skin tissues were fixed and apoptotic
cells were counted using light microscopy. The histological examination
was confirmed with a pathologist (X.G.) and two-way analysis of
variance (ANOVA) was used to assess the effects of TPA and Protandim
on the number of apoptotic cells present per 100 cells. Tukey-Kramer
method was used in the adjustment for multiple comparisons.
Statistical software SAS system 9.3 (SAS Inc. Gary, NC) was used for
two-way ANOVA data analysis. *, significantly different from Ctrl Veh:
DMSO; #, significantly different from Ctrl/TPA. Ctrl: control basal diet
(AIN-76A); Veh: Vehicle control (DMSO); Pro: Protandim-containing diet;
TPA: 12-O-tetradecanoylphorbol-13-acetate.
doi:10.1371/journal.pone.0011902.g001
Figure 2. Western blot analysis of p53 and Bax in mitochondrial fraction (left) and examination of apoptosis (right) in mouse skin
epidermal tissues. Succinate dehydrogenase subunit B (SDHB) served as the loading control. The levels of p53/Bax were normalized to that of
SDHB. Statistical analysis was performed using one-way ANOVA (for multiple group comparison) followed by Newman-Keuls post-test. Ctrl, basal diet;
Veh, vehicle control (DMSO); Pro, Protandim. *, p,0.05 when compared to DMBA/TPA group; #, significantly different from Ctrl/TPA.
doi:10.1371/journal.pone.0011902.g002
Protandim on Apoptosis
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Protandim can induce several endogenous antioxidant enzymes to
reduce tumorigenesis in the two-stage skin carcinogenesis mouse
model. Protandim induces the antioxidant enzyme, MnSOD, which
has been shown to suppress tumorigenesis in vivo. In addition,
Protandim also suppressed TPA-induced cell transformation of JB6
P+ cells (Table S1). We compared MnSOD in vitro levels between
JB6 P+ and P- cells. Our studies showed that JB6 P+ cells express
lower levels of MnSOD compared to JB6 P- cells (Figure 4A).
Molecular cross-talk exists between p53 and MnSOD which leads to
reducedMnSODexpressionandactivity[23,24].Theseresultswere
further confirmed using NBT-BCS SOD inhibition assay. Herein,
the results showed significantly lower levels of MnSOD activity in
JB6 P+ cells compared to JB6 P- cells. Therefore, tumor promotion
sensitive JB6 P+ cells, that express higher levels of p53, have reduced
levels of MnSOD expression and activity. Conversely, JB6 P- cells,
that possess a tumor promotion resistant phenotype, express lower
levels of p53 and higher levels of mitochondrial MnSOD activity
and expression. In addition, the levels of oxidative stress in both cell
lines were detected using DCF staining with or without TPA
treatment.Asshown inFigure4B,withoutTPAtreatment, the ROS
levels in JB6 P- cells were approximately 60% of that in JB6 P+ cells.
Figure 3. The expression levels of p53 and Bax after TPA (100 nM) treatment in JB6 promotable (P+) and non-promotable (P-) cells.
TPA induced p53 activation and apoptosis only in P+ cells, not P- cells. Total cell lysate was used for the assay. The cells were grown in EMEM medium
supplemented with 4% fetal bovine serum, 2 mM of L-glutamine, 50 mg/ml penicillin and 50 mg/ml streptomycin. 12-O-tetradecanoylphorbol-13-
actetate (TPA) was prepared as a 20 nM stock solution in dimethylsulfoxide (DMSO). The TPA stock solution was diluted directly in the cell culture
medium, with the resulting concentration being 100 nM. Ctrl: vehicle (0.1% DMSO) treatment for 24 h. *, p,0.05 when compared with the Ctrl group.
doi:10.1371/journal.pone.0011902.g003
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cells, not in P- cells: with TPA treatment, the ROS levels in JB6 P-
were only approximately 30% of that in JB6 P+ cells.
Discussion
p53-mediatedapoptoticsignalingstillremainsan attractive target
mechanism in effective chemotherapeutic drug development. For
years it has been known that p53 can mediate apoptosis by
transcription-dependent mechanisms. However, the cytoplasmic
transcription-independent pool of p53 has recently received
considerable attention [20]. The tumor suppressor p53 can be
activated via DNA damage, hypoxia, oncogene deregulation and
Table 1. Colony Formation in Soft Agar Transformation
Assay.
Vector/Treatment Colonies formed/10
5 cells
GFP/TPA 13.062.65
p53/TPA 33.762.96*
GFP/DMSO 0.0060.00
p53/DMSO 0.3060.33
*p=0.0076 compared with the GFP/TPA 5 nM group.
doi:10.1371/journal.pone.0011902.t001
Figure 4. (A). The expression and activity levels of MnSOD between JB6 non-promotable (P-) and promotable (P+) cells. Mitochondrial fractions were
used for the experiments. The NBT-BCS SOD inhibition assay was used to measure the MnSOD activity. The presence of MnSOD inhibited the NBT
reduction. The data was plotted as percentage inhibition vs. protein concentration. One unit of activity was defined as the amount of protein needed
to inhibit 50% of the NBT reduction rate. NaCN (5 mM) was used to measure MnSOD activity. Higher expression/activity levels of MnSOD were
observed in JB6 P- cells compared to JB6 P+. SDHB served as the mitochondrial marker and loading control. (B). Detection of ROS levels in JB6 cells
using H2DCFDA staining. Cells grown in 96-well plates were incubated with TPA or Vehicle (0.1% DMSO) for 1 h following by incubation with 10 mM
H2DCFDA for 15 min. DCF fluorescence was detected using a fluorescence plate reader (Ex: 485 nm; Em: 528 nm). The fluorescent density was
divided by the protein concentration for fair comparison. *, p,0.05 when compared to its control; #,p ,0.05 when compared with the TPA group.
doi:10.1371/journal.pone.0011902.g004
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translocates to the mitochondria where it physically interacts with
Bax, a mitochondrial protein and p53 transcriptional target.
Following this interaction, lipid pore formation occurs which allows
for p53 mitochondrial entry and the release of apoptotic proteins
such as cytochrome c; as well as, changes in the mitochondrial
membranepotentialandcaspase activation [25].Otherstudieshave
demonstrated that mice treated with DMBA/TPA exhibited
increases in skin epidermal cell proliferation, oxidative stress
generation, and apoptosis [19]. In addition, mechanisms that
contributed to this dual effect where dependent on AP-1 activation,
and p53 expression and localization [19]. Nevertheless, it was found
that DMBA/TPA treatment not only significantly increased p53
nuclear accumulation, but there was also a significant increase in
p53 mitochondrial expression. In this study, apoptosis is associated
with high levels of p53 mitochondrial expression following DMBA/
TPA treatment. In addition, signature apoptotic ultrastructural
changes, such as cell shrinkage, chromatin condensation and dense
nuclear staining are known to occur in mouse skin tissues following
DMBA/TPA treatment. Interestingly, we found that DMBA/TPA
–mediated apoptotic cells, ultrastructural modifications and p53/
Bax mitochondrial translocation were reduced in Protandim-fed
mice compared to control mice that were similarly treated. This
suggests that modulating ROS generation via the induction of
endogenous antioxidant enzymes may regulate p53 mitochondrial
translocation. Thus, the endogenous antioxidant enzyme, MnSOD
may function as a regulator of apoptosis. However, further studies
are needed to clearly elucidate the role of MnSOD in apoptosis
alone. Our in vitro studies showed that p53/Bax expression could
only be induced in tumor promotion sensitive JB6 P+ cells following
TPA treatment; however, this was not seen in promotion-resistant
JB6 P- cells. To further verify the role of p53 expression in tumor
promotion, we transfected promotion-resistant JB6 P- cells with
wild-type p53. Interestingly, we found that p53 expression
significantly induced colony formation in promotion-resistant JB6
P- cells following TPA treatment. Conversely, when observing
MnSOD expression/activity among the JB6 clonal variants, we
found that it was the promotion resistant P- cells that expressed
higher levels of MnSOD activity and mitochondrial expression. On
the otherhand, p53 is modulatedbyTPA-mediatedoxidative stress.
Our results showed that TPA can also modulate the activation of
pro-apoptotic proteins, such as Bax, a downstream p53 transcrip-
tional target. A fraction of p53 is localized to mitochondria at the
onset of p53-dependent apoptosis preceding changes in mitochon-
drial membrane potential, cytochrome c release and caspase
activation [9]. Recall that once localized in mitochondria, p53
interacts with MnSOD and suppresses its activity. However, this is
only one mechanism of p53-mediated MnSOD inactivation. p53
can also bind to the specificity protein -1 (Sp-1) site within the
MnSOD promoter region and suppress MnSOD gene expression
under both constitutive and TPA-induced conditions [21].
Therefore it’s not surprising that promotable cells that possess high
levels of p53 activation have low levels of MnSOD expression.
Conversely,non-promotable cellsthat possess lowlevels of p53have
high levels of MnSOD. Nevertheless, p53 mitochondrial transloca-
tion and its physical interaction with MnSOD can also lead to
increased ROS generation. Previous studies have shown that
mitochondria and mitochondrial-generated ROS contribute to the
apoptotic process [26]. However, we have demonstrated that ROS
generation, resulting in oxidative macromolecule damage, can also
contribute to cell proliferation leading to downstream skin tumor
formation [7]. In addition, it has been shown that cell death
accompanies cell proliferation during tumorigenesis, which may
play both an eliminating and contributing role to carcinogenesis
[13]. It has been suggested that MnSOD may be a novel tumor
suppressor gene. We analyzed the ability of TPA to induce ROS
generation in both clonal variants of JB6 cells and found that TPA
induced a higher level of ROS generation in promotable JB6 P+
cells, which as mentioned above has lower MnSOD activity and
higherlevelsofp53expression and activation.Takentogether,these
results suggest a linkage between tumor promotion, mitochondrial
ROS generation, p53-mediated apoptosis, and MnSOD activity.
MnSOD is a highly inducible protein, and when induced by
dietary compounds such as Protandim, is effective in the
suppression of tumor promotion [23]. The results from this study
further confirmed and extended our previous findings that
Protandim modulates tumorigenesis via the induction of endog-
enous antioxidant enzymes. In addition, Protandim utilizes
multiple mechanisms to modulate cell proliferation and apoptosis
in vivo and in vitro, which both contribute to tumorigenesis.
Therefore, these results further demonstrate the effectiveness of
multi-modal antioxidant base therapies in chemoprevention.
Supporting Information
Figure S1 Ultrastructural detection of cutaneous apoptosis during
early stage skin carcinogenesis. Mouse skin tissues were isolated from
each treatment group. Ultrastructural features were used to identify
apoptosis, such as cell shrinkage, chromatin condensation, dense
nuclear staining, formation of cytoplasmic blebs and apoptotic
bodies. Conventionalelectron microscopy,at low magnification,was
used to obtain images of apoptotic and mitotic cells. The following
ultrastructuralfeaturesarelabeled,apoptoticcells(Ap)wereadjacent
to mitotic cells (M) and areas of hyperplasia in the epidermal layer
above the dermal layer (D), Bar = 5 micrometer. The stratum
corneum (SC) consists of keratin without cellular organelles.
Found at: doi:10.1371/journal.pone.0011902.s001 (10.32 MB
TIF)
Table S1
Found at: doi:10.1371/journal.pone.0011902.s002 (0.06 MB
DOC)
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